SCHEMBL24634487

SCHEMBL24634487

c1ccc(-c2ccc(N(c3ccc4c(c3)c3ccccc3n4-c3ccccc3)c3cccc4c3oc3ccccc34)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.38
ATM Q13315 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
ALOX5 P09917 2/20 0.34
ALDH1A1 P00352 2/20 0.32
TSPO P30536 1/20 0.32
PPARG P37231 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
NR2E3 Q9Y5X4 1/20 0.32
NCOR2 Q9Y618 1/20 0.32
KMT2A Q03164 2/20 0.31
MEN1 O00255 1/20 0.31
POLB P06746 1/20 0.31
TSHR P16473 1/20 0.31
BRCA1 P38398 1/20 0.31
HSD17B10 Q99714 1/20 0.31
HDAC4 P56524 1/20 0.30
PLA2G2A P14555 1/20 0.30
PLA2G4A P47712 1/20 0.30
IL1R1 P14778 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21042079 1.00 KDM4E (0.38) KDM4EATML3MBTL1ALOX5ALDH1A1
SCHEMBL14295329 0.99 KDM4E (0.38) KDM4EATML3MBTL1ALOX5ALDH1A1
SCHEMBL14295333 0.99 KDM4E (0.39) KDM4EATML3MBTL1ALOX5ALDH1A1
SCHEMBL12959813 0.98 KDM4E (0.37) KDM4EATML3MBTL1ALOX5ALDH1A1
SCHEMBL24947427 0.98 KDM4E (0.38) KDM4EATML3MBTL1ALOX5ALDH1A1
SCHEMBL14295316 0.97 KDM4E (0.38) KDM4EATML3MBTL1ALOX5ALDH1A1
SCHEMBL14295328 0.97 KDM4E (0.38) KDM4EATML3MBTL1ALOX5ALDH1A1
SCHEMBL14295317 0.96 KDM4E (0.35) KDM4EATML3MBTL1ALOX5ALDH1A1
SCHEMBL14295325 0.96 KDM4E (0.35) KDM4EATML3MBTL1ALOX5ALDH1A1
SCHEMBL12283617 0.96 KDM4E (0.38) KDM4EATML3MBTL1ALOX5ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220275008-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2022-09-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220275008-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE OCIAD2, OCIAD1, OXER1 KDM4E 4378/4885ATM 3631/4885L3MBTL1 4715/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.